Literature DB >> 26029458

The functional and prognostic implications of regulatory T cells in colorectal carcinoma.

Xinhai Zhang1, Sonia Kelaria1, Justin Kerstetter1, Jun Wang1.   

Abstract

One of the cornerstones for the immune system is the discovery of T-regulatory cells (Treg), which play an essential role in maintaining self regulation of the immune response to foreign threats. However, they may also interfere with the immune response to tumoral cells, for which reason much effort has been put into characterizing the molecular makeup of this T cell population. It has been shown that Tregs are increased in the peripheral blood of patients with many cancer types, and also enriched in the tumor sites. However, the significance of this phenomenon on prognosis is controversial, especially in colorectal carcinoma, one of the most common cancers worldwide and a major cause of cancer-related death. This literature review focuses on characterization of the Treg cells in colorectal cancer patients and its implications on the prognosis of this disease. In the end, the potential therapeutic strategies aimed at Treg modification are discussed.

Entities:  

Keywords:  Colorectal carcinoma; T-regulatory cells (Treg); prognosis

Year:  2015        PMID: 26029458      PMCID: PMC4397244          DOI: 10.3978/j.issn.2078-6891.2015.017

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  43 in total

1.  Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.

Authors:  Li-Yuan Chang; Yung-Chang Lin; Jayashri Mahalingam; Ching-Tai Huang; Ten-Wen Chen; Chiao-Wen Kang; Hui-Min Peng; Yu-Yi Chu; Jy-Ming Chiang; Avijit Dutta; Yuan-Ji Day; Tse-Ching Chen; Chau-Ting Yeh; Chun-Yen Lin
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

Review 2.  Targeting regulatory T cells in cancer.

Authors:  William L Byrne; Kingston H G Mills; James A Lederer; Gerald C O'Sullivan
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

3.  Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.

Authors:  Kyung-Ju Kim; Kyu Sang Lee; Hwa Jin Cho; Young Hoon Kim; Han Kwang Yang; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Hum Pathol       Date:  2013-12-12       Impact factor: 3.466

Review 4.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

5.  LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

Authors:  Chiara Camisaschi; Chiara Casati; Francesca Rini; Michela Perego; Annamaria De Filippo; Frédéric Triebel; Giorgio Parmiani; Filiberto Belli; Licia Rivoltini; Chiara Castelli
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

6.  Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.

Authors:  Quanrongzi Wang; Min Feng; Tongfu Yu; Xisheng Liu; Peijian Zhang
Journal:  Cell Immunol       Date:  2014-01-10       Impact factor: 4.868

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 8.  Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy.

Authors:  Mario P Colombo; Silvia Piconese
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 9.  Metabolic control of regulatory T cell development and function.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Trends Immunol       Date:  2014-09-20       Impact factor: 16.687

10.  Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.

Authors:  Mathieu F Chevalier; Céline Didier; Gaël Petitjean; Marina Karmochkine; Pierre-Marie Girard; Françoise Barré-Sinoussi; Daniel Scott-Algara; Laurence Weiss
Journal:  J Infect Dis       Date:  2014-10-03       Impact factor: 5.226

View more
  30 in total

Review 1.  High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cancer Immunol Immunother       Date:  2016-02-24       Impact factor: 6.968

2.  Cell-to-cell distances between tumor-infiltrating inflammatory cells have the potential to distinguish functionally active from suppressed inflammatory cells.

Authors:  S Nagl; M Haas; G Lahmer; M Büttner-Herold; G G Grabenbauer; R Fietkau; L V Distel
Journal:  Oncoimmunology       Date:  2016-01-13       Impact factor: 8.110

Review 3.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

4.  mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model.

Authors:  Adi Sharbi-Yunger; Mareike Grees; Esther Tzehoval; Jochen Utikal; Viktor Umansky; Lea Eisenbach
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

5.  Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.

Authors:  Yuping Cai; Xinyi Shen; Lingeng Lu; Hong Yan; Huang Huang; Patricia Gaule; Engjel Muca; Casey M Theriot; Zahra Rattray; Nicholas J W Rattray; Jun Lu; Nita Ahuja; Yawei Zhang; Philip B Paty; Sajid A Khan; Caroline H Johnson
Journal:  Biol Sex Differ       Date:  2022-10-23       Impact factor: 8.811

Review 6.  The Role of the Gut Microbiome in Colorectal Cancer.

Authors:  Grace Y Chen
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

7.  Determination of a CD4+CD25-FoxP3+ T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-γ.

Authors:  Morteza Jafarinia; Fereshteh Mehdipour; Seyed Vahid Hosseini; Leila Ghahramani; Masood Hosseinzadeh; Abbas Ghaderi
Journal:  Tumour Biol       Date:  2016-09-13

8.  Systemic and local inflammation in colorectal cancer.

Authors:  Roberts Rumba; Sandra Cipkina; Fanija Cukure; Andrejs Vanags
Journal:  Acta Med Litu       Date:  2018

9.  Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer.

Authors:  Song VAN Nguyen; Levar Shamoun; Kalle Landerholm; Roland E Andersson; Dick Wagsater; Jan Dimberg
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery.

Authors:  Liwei Jiang; Sungwook Jung; Jing Zhao; Vivek Kasinath; Takaharu Ichimura; John Joseph; Paolo Fiorina; Andrew S Liss; Khalid Shah; Nasim Annabi; Nitin Joshi; Tomoya O Akama; Jonathan S Bromberg; Motohiro Kobayashi; Kenji Uchimura; Reza Abdi
Journal:  Nano Today       Date:  2020-12-14       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.